Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$12.02 - $13.41 $83,178 - $92,797
-6,920 Reduced 84.32%
1,287 $17,000
Q3 2023

Nov 07, 2023

BUY
$11.6 - $12.52 $1,241 - $1,339
107 Added 1.32%
8,207 $101,000
Q2 2023

Aug 07, 2023

BUY
$12.02 - $13.07 $97,362 - $105,867
8,100 New
8,100 $100,000
Q2 2018

Aug 10, 2018

SELL
$3.86 - $7.61 $59,027 - $116,372
-15,292 Closed
0 $0
Q3 2017

Nov 06, 2017

BUY
$9.13 - $11.72 $139,615 - $179,222
15,292
15,292 $222,000

Others Institutions Holding MACK

About MERRIMACK PHARMACEUTICALS INC


  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.